Form 4: AbbVie Director Rebecca B. Roberts Reports Stock Award and Disposal

Director Rebecca B. Roberts reports acquisition of 1,203 shares of AbbVie common stock through restricted stock units and disposal of 13,728 shares.

Summary

• On May 9, 2025, Rebecca B. Roberts, a director of AbbVie Inc., reported a transaction involving AbbVie's common stock.
• Roberts acquired 1,203 shares of common stock through restricted stock units (RSUs) awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These RSUs will be paid in shares of AbbVie common stock on a one-to-one basis upon the earlier of separation from service, death, or a change in control.
• Roberts also disposed of 13,728 shares of common stock.
• Following these transactions, Roberts beneficially owns 13,728 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock upon the occurrence of certain events such as separation from service, death, or a change in control.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This filing indicates changes in Director Roberts' holdings of AbbVie stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the stock transactions of a company director.
• The transactions may have a minor impact on the overall stock price due to the volume of shares involved.

Key Dates

Keywords

AbbVie, Director, Rebecca B. Roberts, Form 4, Stock, Restricted Stock Units, ABBV, Beneficial Ownership, Transaction